EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Risk Factors for Pulmonary Hypertension and Survival in Hemodialysis Patients: Are We Overlooking Serum Magnesium?

Jinhui Song, Xueqin Bian, Bing Zhuang, Xin Liu, Yuan Luo, Guiling Wei, Hong Ye, Chunsun Dai

Kidney Diseases · 23.05.2026 · 12 (1) · 554-563

DOI: 10.1159/000552656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 23.05.2026. Verfasst von Jinhui Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pulmonary hypertension (PH) is a major complication in patients undergoing maintenance hemodialysis (MHD), significantly elevating the risk of cardiovascular events and mortality and severely impairing quality of life.

Methods

In this single-center retrospective study, 1,077 MHD patients were enrolled. PH was diagnosed via echocardiography, and relevant clinical data were collected.

Results

The prevalence of PH was 33.8% (364 cases). Nonlinear regression analysis indicated a significant inverse correlation between serum magnesium levels and PH. Notably, the risk of PH increased substantially when serum magnesium fell below 0.98 mmol/L. After adjusting for confounders (age, hemoglobin, serum phosphorus, NT-proBNP, left ventricular ejection fraction, extracellular water ratio, and pleural effusion), patients in the high-magnesium group (≥0.98 mmol/L) exhibited a 49.9% lower risk of PH (p = 0.026). Survival analysis further confirmed that hypomagnesemia was associated with a 65% and 89% increase in mortality risk among non-PH and PH patients, respectively.

Conclusion

This study provides the evidence that hypomagnesemia is an independent risk factor for PH in MHD patients and is closely associated with adverse clinical outcomes. Management of hypomagnesemia is particularly crucial in MHD patients with PH.

Schlagwörter

Stichwörter der Autor:innen

HemodialysisPulmonary hypertensionRisk factorsSerum magnesium

Autor:innen und Institutionen

  • Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Zitieren

APA

Song, J., Bian, X., Zhuang, B., Liu, X., Luo, Y., Wei, G., Ye, H., & Dai, C. (2026). Risk Factors for Pulmonary Hypertension and Survival in Hemodialysis Patients: Are We Overlooking Serum Magnesium?. Kidney Diseases, 12(1), 554-563. https://doi.org/10.1159/000552656

Vancouver

Song J, Bian X, Zhuang B, Liu X, Luo Y, Wei G, et al. Risk Factors for Pulmonary Hypertension and Survival in Hemodialysis Patients: Are We Overlooking Serum Magnesium?. Kidney Diseases. 2026;12(1):554-563. doi:10.1159/000552656

BibTeX
@article{Song2026,
  author = {Song, Jinhui and Bian, Xueqin and Zhuang, Bing and Liu, Xin and Luo, Yuan and Wei, Guiling and Ye, Hong and Dai, Chunsun},
  title = {Risk Factors for Pulmonary Hypertension and Survival in Hemodialysis Patients: Are We Overlooking Serum Magnesium?},
  journal = {Kidney Diseases},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {554--563},
  doi = {10.1159/000552656}
}
Kostenlos starten →